4261 - 4270 of 6420 Results
Title
Year
-
OPENTitle: The Added Benefit of Opicapone When Used Early in Parkinson's Disease Patients With Levodopa-Induced Motor Fluctuations: A Post-hoc Analysis of BIPARK-I and -IIJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.754016Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.754016/pdfCitation Count: 10
-
OPENTitle: Radiosynthesis, In Vitro and In Vivo Evaluation of [18F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-TauopathiesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 12Issue #: 4Start Page: 596End Page: 602Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.0c00801Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9350900Citation Count: 46
-
OPENTitle: Effect of Urate-Elevating Inosine on Early Parkinson Disease ProgressionJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 326Issue #: 10Start Page: 926End Page: 926Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2021.10207Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2784144/jama_schwarzschild_2021_oi_210070_1631212847.50479.pdfCitation Count: 132
-
OPENTitle: PARIS farnesylation prevents neurodegeneration in models of Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 13Issue #: 604Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aax8891Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9990146Citation Count: 54
-
OPENTitle: Longitudinal clustering analysis and prediction of Parkinson’s disease progression using radiomics and hybrid machine learningJournal Name: Quantitative Imaging in Medicine and SurgeryPublisher: AME Publishing CompanyVol: 12Issue #: 2Start Page: 906End Page: 919Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.21037/qims-21-425Best OA location URL: https://qims.amegroups.com/article/viewFile/78913/pdfCitation Count: 29
-
OPENTitle: An efficient and scalable synthesis of thiazolo ring fused 2-pyridones using flow chemistryJournal Name: ArkivocPublisher: ARKAT USA, Inc.Vol: 2020Issue #: 7Start Page: 365End Page: 378Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.24820/ark.5550190.p011.445Best OA location URL: https://www.arkat-usa.org/get-file/72918/Citation Count: 0
-
OPENTitle: Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosisJournal Name: Journal of Managed Care & Specialty PharmacyPublisher: Academy of Managed Care PharmacyVol: 27Issue #: 6Start Page: 785End Page: 790Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.18553/jmcp.2021.27.6.785Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10391001/pdf/jmcp.2021.27.6.785.pdfCitation Count: 10
-
OPENTitle: Extracellular Vesicles as Novel Diagnostic and Prognostic Biomarkers for Parkinson’s DiseaseJournal Name: Aging and diseasePublisher: Aging and DiseaseVol: 12Issue #: 6Start Page: 1494End Page: 1494Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.14336/ad.2021.0527Best OA location URL: http://www.aginganddisease.org/EN/article/downloadArticleFile.do?attachType=PDF&id=148118Citation Count: 47
-
OPENTitle: Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase InhibitionJournal Name: Molecular Cancer TherapeuticsPublisher: American Association for Cancer Research (AACR)Vol: 20Issue #: 1Start Page: 64End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1158/1535-7163.mct-20-0259Best OA location URL: https://aacrjournals.org/mct/article-pdf/20/1/64/1866868/64.pdfCitation Count: 13
-
OPENTitle: Dysregulation of the AP2M1 phosphorylation cycle by LRRK2 impairs endocytosis and leads to dopaminergic neurodegenerationJournal Name: Science SignalingPublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 693Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scisignal.abg3555Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8486338Citation Count: 26